Economic evaluation of shortened, bedaquiline-containing treatment regimens for rifampicin-resistant tuberculosis (STREAM stage 2): a within-trial analysis of a randomised controlled trial. (2023)

First Author: Rosu L

Attributed to: Tuberculosis Treatment Trials funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s2214-109x(22)00498-3

PubMed Identifier: 36565704

Publication URI: http://europepmc.org/abstract/MED/36565704

Type: Journal Article/Review

Volume: 11

Parent Publication: The Lancet. Global health

Issue: 2

ISSN: 2214-109X